iFabrick (IFA) Planet MicroCap Showcase: VEGAS 2025 summary

Company overview and strategy

• Operates as a hybrid textile technology company, designing and manufacturing products with proprietary technologies for diverse markets.

• Focuses on mass merchants and utilitarian products, providing resilience during economic downturns.

• Maintains a strong licensing strategy while also developing and promoting its own brands, aiming for increased brand visibility and higher revenue rates.

• Management holds a significant ownership stake, aligning interests with long-term growth.

Market focus and growth

• Targets the global enhanced textile market, with a long-term strategy centered on medical applications and antimicrobial textiles.

• Achieved five consecutive years of sales growth, reaching $27.3 million in 2024, up 20% year-over-year.

• Largest division saw a 25% increase, with intelligent fabrics expected to drive future growth to $50–$60 million in the next 3–4 years.

• Expanding into new product categories, with 2025 and 2026 product developments already underway.

Technology and innovation

• Develops multiple proprietary technologies, including PROTX2 antimicrobial products and fluorocarbon-free water repellents.

• Invests heavily in independent third-party lab testing to ensure efficacy and regulatory compliance.

• Holds patents and continues to innovate, with next-generation products in development.